PT Metro Healthcare Indonesia Tbk (ISX:CARE) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:CARE PT Metro Healthcare Indonesia Tbk ISX:CARE
76 GF Score
Price Rp418.00
GF Value Rp370.33
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is PT Metro Healthcare Indonesia Tbk Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

PT Metro Healthcare Indonesia Tbk Valuation Rank Related Terms

ISX:CARE
76GF Score
PT Metro Healthcare Indonesia Tbk ISX:CARE
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?

Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued. The current stock price of Rp418.00 is trading 12.9% above its estimated GF Value™ of Rp370.33. GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.

Key valuation signals for ISX:CARE:

  • Valuation Rank:
  • GF Value™: Rp370.33 vs. price of Rp418.00 (12.9% above fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Metro Healthcare Indonesia Tbk Business Description

Address Jalan Raya Serang Km 16,8, RT / RW 005/001, Kel. Sukamulya, Kec. Cikupa, Tangerang, IDN, 15710
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
76GF Score

Get the complete analysis for ISX:CARE

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp418.00
Price
Rp370.33
GF Value